| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS | 270,909 | 38,856,000 | 13.93% | ||
| 2 | ENANTA PHARMACEUTICALS INC COM | 1,055,719 | 35,367,000 | 12.68% | ||
| 3 | GILEAD SCIENCES INC | 420,000 | 30,076,000 | 10.78% | ||
| 4 | SUCAMPO PHARMACEUTICALS INC | 1,863,755 | 25,254,000 | 9.05% | ||
| 5 | ORTHOFIX INTERNATIONAL NV | 645,530 | 23,355,000 | 8.37% | ||
| 6 | HALYARD HEALTH INC | 564,792 | 20,886,000 | 7.49% | ||
| 7 | AMGEN INC | 127,157 | 18,592,000 | 6.67% | ||
| 8 | Indivior Plc Ord | 4,650,416 | 16,973,000 | 6.09% | ||
| 9 | MERCK & CO INC | 252,874 | 14,887,000 | 5.34% | ||
| 10 | CONMED CORP | 328,677 | 14,518,000 | 5.21% | ||
| 11 | INVACARE CORP COM | 1,102,586 | 14,389,000 | 5.16% | ||
| 12 | RTI SURGICAL HOLDINGS INC COM | 4,216,948 | 13,705,000 | 4.91% | ||
| 13 | DERMA SCIENCES INC COM PAR .01 | 891,026 | 4,633,000 | 1.66% | ||
| 14 | AVIRAGEN THERAPEUTICS INC | 2,737,602 | 3,367,000 | 1.21% | ||
| 15 | DIGIRAD CORP | 486,400 | 2,432,000 | 0.87% | ||
| 16 | JUNIPER PHARMACEUTICALS INC COM | 290,853 | 1,629,000 | 0.58% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001609251-17-000001, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
